Increased fracture risk after discontinuation of anti|osteoporosis ...

Increased fracture risk after discontinuation of anti-osteoporosis ...

Discontinuation of denosumab resulted in an increased risk of major osteoporotic fractures, especially vertebral fractures. The increased risk tends to ...

Increased fracture risk after discontinuation of anti‐osteoporosis ...

Discontinuation of denosumab resulted in an increased risk of major osteoporotic fractures, especially vertebral fractures. The increased risk ...

Increased fracture risk after discontinuation of anti-osteoporosis ...

Regarding: Increased fracture risk after discontinuation of anti-osteoporosis medications among hip fracture patients.

Bone Mineral Density Loss and Fracture Risk After Discontinuation ...

Discontinuation of anti-osteoporotic agents for 1 year leads to a decrease in BMD. Osteoporosis should be considered more as a chronic condition ...

Fracture risk following intermission of osteoporosis therapy - Esceo

When comparing fracture-risk outcomes after 5 years, clinically recognised ver- tebral fractures were significantly more common among those discontinuing ...

Increased Risk of Vertebral Fracture After Stopping Denosumab

If denosumab needs to be stopped, it should be replaced by an alternative osteoporosis medication to help prevent rapid bone loss and risk of ...

Sustained Vertebral Fracture Risk Reduction After Withdrawal of ...

Methods This study is a follow-up to the Fracture Prevention Trial (FPT), a randomized, placebo-controlled study of postmenopausal women with osteoporosis ...

Discontinuing Denosumab: Can It Be Done Safely? A Review of the ...

treatment [11,19], and a higher rate of bone loss after stopping. [15] have been identified as risk factors for vertebral fractures after denosumab ...

Increased fracture risk after discontinuation of anti‐osteoporosis ...

Results Compared with persistent denosumab users, non‐persistent denosumab users had a significantly higher risk of major osteoporotic fractures (hazard ratio [ ...

osteoporosis medications among hip fracture patients: A population

Increased fracture risk after discontinuation of anti-osteoporosis medications among hip fracture patients: A population-based cohort study.

Increased fracture risk after discontinuation of anti-osteoporosis ...

Discussion: Discontinuation of denosumab resulted in an increased risk of major osteoporotic fractures, especially vertebral fractures. The increased risk tends ...

Denosumab cessation | Cleveland Clinic Journal of Medicine

Since fracture risk increases rapidly after denosumab discontinuation and multiple vertebral fractures occur with greater frequency, it is ...

Increased fracture risk after discontinuation of anti‐osteoporosis ...

Discussion: Discontinuation of denosumab resulted in an increased risk of major osteoporotic fractures, especially vertebral fractures. The increased risk tends ...

OP0035 RISK OF FRAGILITY FRACTURE AFTER LONG-TERM ...

Conclusion: In our analysis of French claims data, over half of women initiating oral BP between 2015 and 2020 discontinued treatment for at least one year, ...

Fracture Prediction After Discontinuation of 4 to 5 Years of ...

Interestingly, greater individual treatment-related reductions in bone turnover are associated with increased fracture risk among postmenopausal ...

Osteoporosis Treatment: When to Discontinue and When to Re-start

These are also the drugs with the most persistent “tail effect” concerning bone turnover, BMD values, and fracture risk. The anti-fracture ...

Fracture incidence after denosumab discontinuation: Real-world ...

Patients who discontinue DMAB are at greater risk of major OP fractures than those who persist with treatment. Same is true for clinical multiple vertebral ...

Fracture Risk and Management of Discontinuation of Denosumab ...

Denosumab discontinuation leads to a complete and rapid reversal of its effects on BTMs and BMD. Six months after the last denosumab injection, BTMs increase ...

Section 7: Strategies for management of osteoporosis and fracture risk

Withdrawal of bisphosphonate treatment is associated with decreases in BMD and increased bone turnover after 2-3 years for alendronate; (Evidence level Ib), and ...

Rapid Bone Loss and Multiple Vertebral Fractures After Denosumab ...

Since fracture risk increases rapidly after denosumab discontinuation and multiple vertebral fractures ... osteoporosis, including the ...